Dosage Form Design for Low and Middle-Income Countries

There are many factors contributing to inadequate access to medicines in low- and middle-income countries (LMIC). The problem is complex, but ultimately results in more than 2 billion people in LMICs having a lack of access to medicine. Furthermore, about 70% of cancer deaths occur in LMIC, yet LMICs have less than 5% share of the global resources for combating cancer. A truly dire situation requiring a multi-faceted approach to contribute to overcoming these challenges.

In this article, Terry Ernest, Director of Manufacturing Science and Technology, Almac Pharma Services, shares several key insights regarding dosage form design for low and middle-income countries.